Cevidoplenib

For research use only. Not for therapeutic Use.

  • CAT Number: I015067
  • CAS Number: 1703788-21-9
  • Molecular Formula: C25H27N7O3
  • Molecular Weight: 473.53
  • Purity: ≥95%
Inquiry Now

Cevidoplenib (Cat No.:I015067) is an orally active, reversible covalent inhibitor of Bruton’s tyrosine kinase (BTK), a critical enzyme in B-cell receptor signaling. By blocking BTK, it suppresses B-cell activation, proliferation, and survival, thereby reducing aberrant immune responses. Cevidoplenib is under investigation for the treatment of autoimmune and inflammatory diseases, including immune thrombocytopenia (ITP), rheumatoid arthritis, and other B-cell–mediated disorders. Researchers use Cevidoplenib to study B-cell signaling pathways, immune modulation, and therapeutic approaches targeting BTK. Its oral bioavailability makes it a promising candidate for chronic disease management.


CAS Number 1703788-21-9
Synonyms

cyclopropyl-[5-[[4-[4-[[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]methyl]-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]-1-methylindol-3-yl]methanone

Molecular Formula C25H27N7O3
Purity ≥95%
IUPAC Name cyclopropyl-[5-[[4-[4-[[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]methyl]-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]-1-methylindol-3-yl]methanone
InChI InChI=1S/C25H27N7O3/c1-15-17(10-31-12-19(33)14-35-31)11-32(29-15)23-7-8-26-25(28-23)27-18-5-6-22-20(9-18)21(13-30(22)2)24(34)16-3-4-16/h5-9,11,13,16,19,33H,3-4,10,12,14H2,1-2H3,(H,26,27,28)/t19-/m0/s1
InChIKey YCZUBLQESBVOSH-IBGZPJMESA-N
SMILES CC1=NN(C=C1CN2C[C@@H](CO2)O)C3=NC(=NC=C3)NC4=CC5=C(C=C4)N(C=C5C(=O)C6CC6)C
Chemistry Calculators Dilution Calculator
In vivo Formulation Calculator
Molarity Calculator
Molecular Weight Calculator
Reconstitution Calculator

Request a Quote